M. Pauly

Most-cited papers

1. Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C Infected Patients with Compensated and Decompensated Cirrhosis

   Varun Saxena, L. Nyberg, M. Pauly, Aditi Dasgupta +6 more

   2015Hepatology104 citations Open access

   Semantic Scholar

   Save

2. Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long‐term Treatment With Tumor Necrosis Factor Antagonists

   M. Pauly, L. Tucker, J. Szpakowski, J. Ready +3 more

   2018Clinical Gastroenterology and Hepatology65 citations

   Semantic Scholar

   Save

3. No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients

   J. Marcus, L. Hurley, Scott Chamberland, J. Champsi +11 more

   2018Clinical Gastroenterology and Hepatology59 citations Open access

   Semantic Scholar

   Save

4. Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017

   S. Seo, M. Silverberg, L. Hurley, J. Ready +9 more

   2019Clinical Gastroenterology and Hepatology45 citations Open access

   Semantic Scholar

   Save

5. The Impact of Lifetime Alcohol Use on Hepatitis C Treatment Outcomes in Privately Insured Members of an Integrated Health Care Plan

   M. Russell, M. Pauly, C. Moore, Constance Chia +4 more

   2012Hepatology33 citations Open access

   Semantic Scholar

   Save

6. Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis

   Varun Saxena, M. Manos, Helen S. Yee, Lisa Catalli +7 more

   2014Alimentary Pharmacology and Therapeutics27 citations Open access

   Semantic Scholar

   Save

7. Eight- or 12-Week Treatment of Hepatitis C with Ledipasvir/Sofosbuvir: Real-World Experience in a Large Integrated Health System

   Jennifer B. Lai, M. Witt, M. Pauly, J. Ready +3 more

   2017Drugs24 citations

   Semantic Scholar

   Save

8. Histopathology of early and late human allograft rejection

   B. Ruebner, M. Pauly, N. Pimstone, Richard E. Ward +10 more

   1987Hepatology7 citations

   Semantic Scholar

   Save

9. Obesity and high body weights predict ledipasvir/sofosbuvir treatment failure

   Jin-Ping Lai, M. Witt, J. Ready, M. Pauly +1 more

   20172 citations

   Semantic Scholar

   Save

10. The Impact of Lifetime Drug Use on Hepatitis C Treatment Outcomes in Insured Members of an Integrated Health Care Plan

    M. Russell, M. Pauly, C. Moore, Constance Chia +3 more

    2013Drug and Alcohol Dependence2 citations Open access

    Semantic Scholar

    Save

11. P0876 : Safety and efficacy of simeprevir/sofosbuvir in Hepatitis C (HCV) infected patients with varying severity of cirrhosis: comparison to matched untreated and Protease Inhibitor (PI)-Triple therapy treated controls

    Varun Saxena, L. Nyberg, M. Pauly, J. Ready +12 more

    20151 citations

    Semantic Scholar

    Save

12. Hepatotoxicity with Chemotherapy in Patients Infected with Hepatitis C

    J. Szpakowski, L. Tucker, D. Baer, M. Pauly

    20160 citations

    Semantic Scholar

    Save

13. 450 Simeprevir/Sofosbuvir Therapy in Hepatitis C (HCV) Infected Patients With Child-Pugh Class B/C Cirrhosis Compared to Matched Untreated and Protease Inhibitor (PI)-Triple Therapy Treated Control

    Varun Saxena, L. Nyberg, M. Pauly, J. Ready +12 more

    20150 citations

    Semantic Scholar

    Save